Sanofi India net down 6.38 pc at Rs 51.3 cr in July-September
Drug firm Sanofi India today said its net profit declined by 6.38 per cent to Rs 51.3 crore for the quarter ended September 30, 2012, mainly due to increase in the cost of materials and amortisation costs.
By PTI |
NEW DELHI: Drug firm Sanofi India today said its net profit declined by 6.38 per cent to Rs 51.3 crore for the quarter ended September 30, 2012, mainly due to increase in the cost of materials and amortisation costs.
The company had posted a net profit of Rs 54.8 crore for the same quarter last fiscal.
Total income from operations of the company however rose to Rs 416 crore for the quarter under consideration from Rs 332.5 crore for the corresponding period previous fiscal, Sanofi India said in a BSE filing.
The profit for the quarter and nine months ended September 30, 2012 had been impacted due the amortisation costs relating to brands, technical know-how and goodwill acquired from Universal Medical and lower interest income as a result of the that, Sanofi India said.
Shares of Sanofi India today closed at Rs 2,247.95 apiece on the BSE, up 2.39 per cent from their previous close.
The company had posted a net profit of Rs 54.8 crore for the same quarter last fiscal.
Total income from operations of the company however rose to Rs 416 crore for the quarter under consideration from Rs 332.5 crore for the corresponding period previous fiscal, Sanofi India said in a BSE filing.
The profit for the quarter and nine months ended September 30, 2012 had been impacted due the amortisation costs relating to brands, technical know-how and goodwill acquired from Universal Medical and lower interest income as a result of the that, Sanofi India said.
Shares of Sanofi India today closed at Rs 2,247.95 apiece on the BSE, up 2.39 per cent from their previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
